International journal of medical microbiology : IJMM · 2016
High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Janssen Iryna, Cooper Paul, Gunka Katrin, Rupnik Maja, Wetzel Daniela, Zimmermann Ortrud, Groß Uwe
Аннотация
Since data about Clostridium difficile infection in sub-Saharan Africa are scarce, we determined its epidemiology and risk factors in a cross-sectional study in Eikwe, a rural community in Ghana. We tested stool samples from 176 hospitalized patients with diarrhoea and from 131 asymptomatic non-hospitalized individuals for C. difficile and some other enteric pathogens. The overall prevalence rate of C. difficile was 4.9% with ribotype 084 being predominant. With 75% of the isolates, a high rate of nontoxigenic strains was present in symptomatic patients, most of whom had no other identified enteric pathogens. All strains were susceptible against metronidazole and vancomycin, respectively. Data on lifestyle and medical history showed that age <5years (p=0.004), and use of ceftriaxone (p=0.023) were the most important risk factors for C. difficile carriage status. Although our data suggest that C. difficile is currently not a major cause of diarrhoea in this setting, the epidemiology of C. difficile in sub-Saharan Africa awaits further investigation.
Предметные рубрики MeSH
AdolescentAdultAge FactorsAgedAged, 80 and overAnti-Bacterial AgentsBacterial ToxinsCarrier StateCeftriaxoneChildChild, PreschoolClostridioides difficileClostridium InfectionsCross-Sectional StudiesDiarrheaFecesFemaleGhanaHospitalizationHumansInfantInfant, NewbornMaleMetronidazoleMicrobial Sensitivity TestsMiddle AgedPrevalenceProspective StudiesRibotypingRisk FactorsRural PopulationVancomycinYoung Adult